What Researchers Did
Researchers investigated whether hyperbaric oxygen treatment (100% O2 at 2.8 bar) could make the antibiotic ciprofloxacin more effective against *Pseudomonas aeruginosa* biofilms grown in a lab setting.
What They Found
They discovered that reoxygenating the biofilms with HBOT significantly enhanced ciprofloxacin's ability to kill *P. aeruginosa*. This proof-of-principle study demonstrated that combining ciprofloxacin treatment with HBOT has the potential to improve the treatment of *P. aeruginosa* biofilm infections.
What This Means for Canadian Patients
For Canadian patients suffering from chronic *Pseudomonas aeruginosa* infections, especially those with cystic fibrosis, this research offers a potential new treatment strategy. Combining HBOT with existing antibiotics like ciprofloxacin could lead to more effective ways to combat stubborn biofilm infections that are often resistant to standard treatments.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a proof-of-principle study conducted in a lab using artificial biofilms, meaning further human studies are needed to confirm these effects.